RespireRx Pharmaceuticals Inc (RSPI)

[LTListener]

Maybe, maybe not. I think anything different than status quo sometimes is interesting.

Jump in volume. Ignoring the 10-k completely. Silence. All could be positive or negative in the end. Logically, though, one would think any preclinicals on the OSA side would be making progress and nearing some advancement.

The bigger fish is the KRM-II-81 progress in tier 3 NIH preclinicals. No word on this progress, but one would think there would be preliminary indications as to whether or not the rats/animals show any addictive liability to the drug. If they move forward, I am curious if NIH would strongly encourage getting this into BP hands and out of OTC world, especially considering no depth in management nor any active CEO in place to manage grant funding for human trials.

The possibilities here are flat out enormous considering the positive progress along multiple drug development paths. IMO, deserving much much higher speculative valuation at minimum. Whether or not they have the goods to get across the goal line is still unknown. Feels like an extended time out to decide how to proceed. A progress update would be beneficial here, IMO.